The global ischemic stroke aspiration systems market accounted for USD 0.65 billion in 2023 and is expected to reach USD 1.93 billion by 2034 with a CAGR of 10.41% during the forecast period 2024-2034. The market will grow due to factors such as the rising incidence of ischemic strokes, technological advancements, growing adoption of minimally invasive procedures, rising awareness and education campaigns, an increased focus on metrics related to the quality of stroke care, and supportive reimbursement policies.
Worldwide, the incidence of ischemic strokes is on the rise due to the combined effects of an aging population and the increased prevalence of risk factors such as diabetes, hypertension, and smoking. The availability of cutting-edge medical technology is essential for the efficient treatment and management of this increase in instances. For instance, in January 2022, the FDA approved Medtronic's most recent version of the Solitaire X Revascularization Device, which expands the company's offering for treating ischemic strokes by mechanical thrombectomy.
By type, the mechanical aspiration systems segment accounted for the highest revenue-grossing segment in the global ischemic stroke aspiration systems market in 2023 owing to the growing adoption of advanced mechanical thrombectomy techniques and devices, which offer effective clot removal and improved patient outcomes compared to traditional methods. For instance, Acandis expanded its product portfolio in the European market in January 2022 when its AIS-Retriever, an aspiration catheter used in mechanical thrombectomy for ischemic stroke treatment, got CE Mark approval. Additionally, the automated aspiration systems segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for innovative, time-saving technologies, improved procedural efficiency, and reduced risk of complications associated with manual and mechanical aspiration systems.
By application, the acute ischemic stroke segment accounted for the highest revenue-grossing segment in the global ischemic stroke aspiration systems market in 2023 owing to the critical need for immediate intervention to restore blood flow to the brain and prevent irreversible damage, driving demand for advanced aspiration systems for acute stroke treatment. For instance, Medtronic enhanced its portfolio for the treatment of intracranial aneurysms, a condition linked to an elevated risk of ischemic stroke, in February 2023 when it announced the FDA's clearance of its Pipeline Flex Embolization Device with Shield Technology. Additionally, the chronic ischemic stroke segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing focus on long-term management and secondary prevention strategies, driving demand for ischemic stroke aspiration systems for chronic stroke care and rehabilitation.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global ischemic stroke aspiration systems market in 2023 owing to the high patient volumes, advanced infrastructure, and specialized stroke units, making hospitals the primary setting for acute stroke treatment and driving demand for ischemic stroke aspiration systems. For instance, Stryker announced in September 2022 that the FDA had cleared their Target Detachable Coils for the treatment of intracranial aneurysms. This new tool will enable neurosurgeons to treat diseases that are linked to a higher risk of ischemic stroke. Additionally, the ambulatory surgical centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend towards same-day surgical procedures, advancements in minimally invasive techniques, and expanding the availability of stroke care in outpatient settings, driving demand for ischemic stroke aspiration systems in ambulatory surgical centers.
North American region is anticipated to have the highest revenue share during the forecast period owing to the robust healthcare infrastructure, high prevalence of risk factors for stroke, advanced medical technologies, and favorable reimbursement policies, driving adoption of ischemic stroke aspiration systems in the North American region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness about stroke management, improving healthcare infrastructure, rising incidence of ischemic stroke, and growing investments in stroke care initiatives, driving demand for ischemic stroke aspiration systems in the Asia Pacific region. For instance, Penumbra further expanded its range of mechanical thrombectomy devices in November 2022 when it reported that the FDA had cleared its JET 7 and JET 7MAX Reperfusion Catheters for the treatment of acute ischemic stroke.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Worldwide, the incidence of ischemic strokes is on the rise due to the combined effects of an aging population and the increased prevalence of risk factors such as diabetes, hypertension, and smoking. The availability of cutting-edge medical technology is essential for the efficient treatment and management of this increase in instances. For instance, in January 2022, the FDA approved Medtronic's most recent version of the Solitaire X Revascularization Device, which expands the company's offering for treating ischemic strokes by mechanical thrombectomy.
By type, the mechanical aspiration systems segment accounted for the highest revenue-grossing segment in the global ischemic stroke aspiration systems market in 2023 owing to the growing adoption of advanced mechanical thrombectomy techniques and devices, which offer effective clot removal and improved patient outcomes compared to traditional methods. For instance, Acandis expanded its product portfolio in the European market in January 2022 when its AIS-Retriever, an aspiration catheter used in mechanical thrombectomy for ischemic stroke treatment, got CE Mark approval. Additionally, the automated aspiration systems segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for innovative, time-saving technologies, improved procedural efficiency, and reduced risk of complications associated with manual and mechanical aspiration systems.
By application, the acute ischemic stroke segment accounted for the highest revenue-grossing segment in the global ischemic stroke aspiration systems market in 2023 owing to the critical need for immediate intervention to restore blood flow to the brain and prevent irreversible damage, driving demand for advanced aspiration systems for acute stroke treatment. For instance, Medtronic enhanced its portfolio for the treatment of intracranial aneurysms, a condition linked to an elevated risk of ischemic stroke, in February 2023 when it announced the FDA's clearance of its Pipeline Flex Embolization Device with Shield Technology. Additionally, the chronic ischemic stroke segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing focus on long-term management and secondary prevention strategies, driving demand for ischemic stroke aspiration systems for chronic stroke care and rehabilitation.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global ischemic stroke aspiration systems market in 2023 owing to the high patient volumes, advanced infrastructure, and specialized stroke units, making hospitals the primary setting for acute stroke treatment and driving demand for ischemic stroke aspiration systems. For instance, Stryker announced in September 2022 that the FDA had cleared their Target Detachable Coils for the treatment of intracranial aneurysms. This new tool will enable neurosurgeons to treat diseases that are linked to a higher risk of ischemic stroke. Additionally, the ambulatory surgical centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend towards same-day surgical procedures, advancements in minimally invasive techniques, and expanding the availability of stroke care in outpatient settings, driving demand for ischemic stroke aspiration systems in ambulatory surgical centers.
North American region is anticipated to have the highest revenue share during the forecast period owing to the robust healthcare infrastructure, high prevalence of risk factors for stroke, advanced medical technologies, and favorable reimbursement policies, driving adoption of ischemic stroke aspiration systems in the North American region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness about stroke management, improving healthcare infrastructure, rising incidence of ischemic stroke, and growing investments in stroke care initiatives, driving demand for ischemic stroke aspiration systems in the Asia Pacific region. For instance, Penumbra further expanded its range of mechanical thrombectomy devices in November 2022 when it reported that the FDA had cleared its JET 7 and JET 7MAX Reperfusion Catheters for the treatment of acute ischemic stroke.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Type, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement
Segmentation: Ischemic Stroke Aspiration Systems Market Report 2023 - 2034
Ischemic Stroke Aspiration Systems Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Manual Aspiration Systems
- Mechanical Aspiration Systems
- Automated Aspiration Systems
Ischemic Stroke Aspiration Systems Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Acute Ischemic Stroke
- Chronic Ischemic Stroke
Ischemic Stroke Aspiration Systems Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Ischemic Stroke Aspiration Systems Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Ischemic Stroke Aspiration Systems Market: Type Estimates & Trend Analysis
8. Ischemic Stroke Aspiration Systems Market: Application Estimates & Trend Analysis
9. Ischemic Stroke Aspiration Systems Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Ischemic Stroke Aspiration Systems Market
12. Europe Global Ischemic Stroke Aspiration Systems Market
13. Asia Pacific Global Ischemic Stroke Aspiration Systems Market
14. Latin America Global Ischemic Stroke Aspiration Systems Market
15. MEA Global Ischemic Stroke Aspiration Systems Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Medtronic plc
- Stryker Corporation
- Penumbra Inc.
- MicroVention Inc.
- Terumo Corporation
- Johnson & Johnson (DePuy Synthes)
- Boston Scientific Corporation
- Acandis GmbH
- Phenox GmbH
- Penumbra Inc.
- InNeuroCo Inc.
- Straub Medical AG
- AngioDynamics Inc.
- Merit Medical Systems Inc.
- Rapid Medical.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 0.65 Billion |
| Forecasted Market Value ( USD | $ 1.93 Billion |
| Compound Annual Growth Rate | 10.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
